|
| 特征 |
情况下,总（%) |
RIPK4表达式 |
价值 |
价值 |
| 低表达情况(%) |
高表达情况(%) |
|
| 组织学类型 |
|
|
|
|
|
| 卵巢浆液性癌 |
124例(80.5%) |
48 (38.7%) |
76例(61.3%) |
22.256 |
< 0.001 |
| 卵巢浆液性囊腺瘤 |
30 (19.5%) |
26 (86.7%) |
4 (13.3%) |
| 年龄 |
|
|
|
|
|
| ≤50 |
59 (38.3%) |
30 (50.8%) |
29 (49.2%) |
0．002 |
0.969 |
| > 50 |
95例(61.7%) |
48 (50.5%) |
47 (49.5%) |
| 卵巢浆液性癌的组织学分级 |
|
|
|
|
|
| 高 |
74例(59.7%) |
21 (28.4%) |
53 (71.6%) |
8.256 |
0.004 |
| 低 |
50 (40.3%) |
27 (54.0%) |
23 (46.0%) |
| LN转移 |
|
|
|
|
|
| 是的 |
31 (25.0%) |
5 (16.1%) |
26 (83.9%) |
8.882 |
0.003 |
| 没有 |
93例(75.0%) |
43 (46.2%) |
50 (53.8%) |
| 临床阶段 |
|
|
|
|
|
| 我 |
35 (28.2%) |
22 (62.9%) |
13 (37.1%) |
14.013 |
0.003 |
| 2 |
12 (9.7%) |
5 (41.7%) |
7 (58.3%) |
| 3 |
68例(54.8%) |
20 (29.4%) |
48 (70.6%) |
| 4 |
9 (7.3%) |
1 (11.1%) |
8 (88.9%) |
| 临床阶段 |
|
|
|
|
|
| 我 |
35 (28.2%) |
22 (62.9%) |
13 (37.1%) |
12.891 |
0．002 |
| 2 |
12 (9.7%) |
5 (41.7%) |
7 (58.3%) |
| iii iv |
77例(62.1%) |
21 (27.3%) |
56 (72.7%) |
| 临床阶段 |
|
|
|
|
|
| i ii |
47 (37.9%) |
27 (57.4%) |
20 (42.6%) |
11.200 |
０．００１ |
| iii iv |
77例(62.1%) |
21 (27.3%) |
56 (72.7%) |
|
|
